MOSAIC - GP cluster randomised trial to reduce partner violence among pregnant women and women with pre-school children |
ACTRN12607000010493/NHMRC 280617 |
Mother and Child Health Research, Vic a.taft@latrobe.edu.au |
Recruitment complete
|
|
|
|
A prospective, randomised, open label trial on the effect of metformin on in-vitro fertilisation outcome in women with polycystic ovary syndrome |
ACTRN12609000510246 |
Reproductive Medicine, Royal Hospital for Women, Barker St, Randwick 2031, NSW
juliette.koch@sesiahs.health.nsw.gov.au |
Not yet recruiting
|
|
|
|
PIVOT - Parenteral intravenous optimal treatment for hypertensive emergencies in pregnancy |
PTO388 |
Annemarie Hennessy |
Recruitment complete
|
|
|
|
FICare - A Family Integrated Care model for the neonatal intensive care unit: a cluster randomised controlled trial |
NCT01852695 |
Mt Sinai Hospital, Canada k.lui@unsw.edu.au |
Currently recruiting
|
|
|
|
Comparative 12 month study of menstrually-signalled use of a combined contraceptive pill versus a combined contraceptive vaginal ring |
ACTRN12609000391279 |
Family Planning NSW (FPNSW), 328-336 Liverpool Road, Ashfield 2131 NSW
janeh@fpnsw.org.au |
Currently recruiting
|
|
|
|
High flow support versus continuous positive airway pressure (CPAP) support in non-acute respiratory support for preterm infants from 30 weeks corrected gestation |
ACTRN12610000677000 |
Ashley McEwan: ashley.mcewan@hotmail.com |
Recruitment complete
|
Newborn respiratory |
|
|
HEPRIN - Heparin for the Prevention of complications related to placental Insufficiency |
ISRCTN88675588 |
Mt Sinai Hospital, Professor Jodie Dodd (Principal Investigator) jodie.dodd@adelaide.edu.u |
Recruitment complete
|
Preeclampsia. Fetal growth |
Women with significant risk factors for placental insufficiency (low PAPP-A, high AFP, high inhibin, high hCG, medical and obstetric risk factors or abdnormal uterine artery Doppler) |
|
Supervised home-based exercise may attenuate the decline of glucose tolerance in obese pregnant women |
|
Assoc/Prof Kym Guelfi |
Recruitment complete
|
Obesity |
|
|
A randomised controlled trial of continuous versus intermittent infusion of vancomycin in neonates |
NCT02210169 |
Murdoch Childrens Research Institute amanda.gwee@rch.org.au |
Currently recruiting
|
|
|
|
TIPPS - Thrombophilia in Pregnancy Prophylaxis Study: a multicentre, multinational, randomised controlled trial of prophylactic low molecular weight heparin in high-risk pregnant thrombophilic women |
ACTRN12608000446369 |
The Ottawa Hospital, Civic Campus, Civic Parkdale Clinic, 463-737 Parkdale Ave, Ottawa, Ontario K1Y 4E9
amclement@ohri.ca |
Currently recruiting
|
|
|
|
Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and post-partum iron deficiency anaemia: a randomised trial |
|
Bernd Froessler |
Recruitment complete
|
|
|
|
e-prem - Improving child and parent outcomes after preterm birth using a web-based early intervention program |
ACTRN12614000906651 |
Murdoch Childrens Research Institute karli.treyvaud@mcri.edu.au |
Discontinued
|
|
|
|
Mirena Intra-Uterine System: Does it Improve Long Term Symptoms in Women with Chronic Pelvic Pain and/or Endometriosis after Laparoscopy? |
ACTRN12608000029392 |
Early Pregnancy, Gynaecological Ultrasound and Advanced Endoscopic Unit, Nepean Centre for Perinatal Care, Nepean Clinical School, Nepean Hospital, Penrith 2750, NSW
gcondous@hotmail.com |
Currently recruiting
|
|
|
|
Effect of antireflux medication, placebo and infant mental health intervention on persistent crying: a randomized clinical trial |
|
Brigid Jordan |
Recruitment complete
|
|
|
|
NIFTY - A multi-centre randomised double blind placebo controlled trial of nifedipine maintenance tocolysis in fetal fibronectin positive women in threatened preterm labour |
ACTRN12613000985785 |
National Women's Health, Auckland Hospital. Dr Emma Parry (Principal Investigator) EmmaP@adhb.govt.nz |
Recruitment complete
|
Preterm birth ? prevention and treatment |
Women with threatened preterm labour, a singleton pregnancy, gestational age between 24 and 34 weeks, intact membranes, positive fetal fibronectin test, completed course of corticosteroids |
|
Randomised controlled trial of a decision aid for labour analgesia for primiparous women |
PT0534/ISRCTN52287533/NHMRC253635&262047 |
Camille Raynes-Greenow |
Recruitment complete
|
|
|
|
A pilot study on delivery suite mask ventilation in extremely preterm infants |
ACTRN12614000245695 |
Neonatal Intensive Care Unit; Westmead Hospital
dharmesh.shah@health.nsw.gov.au; mark.tracy@health.nsw.gov.au |
Currently recruiting
|
|
|
|
DINO-II pilot study - Determining the docosahexaenoic acid dose to obtain plasma and erythrocyte phospholipid fatty acid profiles in preterm infants comparable to term infant profiles: a dose response pilot study. |
ACTRN12610000382077 |
carmel.collins@health.sa.gov.au |
Recruitment complete
|
Newborn nutrition |
Infants born less than 33 weeks gestation after one but before five days of commencing any enteral feeds and with parental/guardian consent. Multiple births will be eligible and will be randomised individually. Women providing breast milk for their infant not taking DHA supplements or willing to stop taking supplements for duration study. |
|
Prediction of normal vaginal delivery |
PT0547 |
Nepean Hospital Hans Peter Dietz |
Discontinued
|
|
|
|
Effectiveness of a modified mother-infant transaction program on outcomes for preterm infants from 3 to 24 months of age |
|
carol.newnham@austin.org.au |
Recruitment complete
|
Parenting |
|
|
Targeted Delivery Suite Intervention Study (TARDIS). A randomised controlled trial of modes of ventilatory support in preterm babies from point of delivery to the neonatal intensive care unit |
ACTRN12609000986279 |
Nepean Hospital mark.tracy@swahs.health.nsw.gov.au |
Currently recruiting
|
Newborn respiratory |
|
|
ACTS - Australasian Collaborative Trial of vitamin C and E supplementation for the prevention of pre-eclampsia |
ISRCTN00416244/NCT00097110/NHMRC207744 |
caroline.crowther@adelaide.edu.au |
Recruitment complete
|
Preeclampsia. Maternal nutrition. Maternal medical conditions |
Nulliparous women with a singleton pregnancy, between 14-22 weeks gestation, a normal blood pressure |
|
Epi-No Trial: Effect of intravaginal balloon device on levator trauma in mothers following childbirth |
ACTRN12609000592246 |
Nepean Hospital, NSW hans.dietz@sydney.edu.au |
Recruitment complete
|
|
|
|
USES Trial - Women's Opinions and Experiences of Prenatal Screening for Down Syndrome |
PT0355 |
caroline.crowther@adelaide.edu.au |
Recruitment complete
|
Fetal surveillance. Fetal anomaly |
Women at less than 14 weeks gestation who have not had a dating scan or nuchal translucency screening |
|
Sugar Babies Study Sugar Babies |
ACTRN12608000623392 |
Newborn Intensive Care, Waikato Hospital, Hamilton Dr Deborah Harrris: deborah.harris@waikatodhb.health.nz |
Recruitment complete
|
|
|
|
Improving oral hygiene to reduce the risk of preterm birth: A randomised controlled trial assessing a high intensity educational intervention |
ACTRN12605000767606 |
caroline.crowther@adelaide.edu.au |
Discontinued
|
Preterm birth ? prevention and treatment |
Women with a singleton pregnancy |
|
HUNTER trial - High-flow nasal cannulae use in non-tertiary centres for early respiratory distress in newborn infants |
ACTRN12614001203640 |
Dr Brett Manley, Newborn Research Centre, The Royal Women's Hospital, Parkville, VIC |
Currently recruiting
|
Neonatology, Respiratory Distress, Preterm Infants, CPAP
|
Preterm and term infants admitted to non-tertiary nurseries with respiratory distress |
|
The influence of acupuncture on the induction of labour for women with a post date pregnancy: a randomised controlled trial. |
PT0348 / ACTRN12606000494538 |
caroline.smith@uws.edu.au |
Recruitment complete
|
Labour and intrapartum care |
Women > or = 41 weeks; singleton pregnancy; cephalic presentation |
|
MONT (mask or nasal tube) Trial: A randomised controlled trial of mask versus nasal tube for the stabilisation of preterm infants (born between 24 and 29 complete weeks gestation) in the delivery room |
ACTRN12610000230055; NTR2061 |
Newborn Services and Neonatal Research, Royal Women's Hospital Omar Kamlin |
Recruitment complete
|
Newborn resuscitation |
|
|
Expulsion of a retained placenta using acupuncture: a randomised controlled trial |
PT0347 |
caroline.smith@uws.edu.au |
Recruitment complete
|
Labour and intrapartum care |
|
|
Adding negative pRESSure to improve healING (the DRESSING trial) |
ACTRN12615000286549 |
NHMRC Centre for Research Excellence in Nursing (NCREN), Centre for Health Practice Innovation (HPI), Menzies Health Institute Qld (MHIQ), GRIFFITH UNIVERSITY, Gold Coast Campus b.gillespie@griffith.edu.au |
Currently recruiting
|
Caesarean section, Negative pressure wound therapy, Surgical site infection |
Pregnant women with BMI ≥30, undergoing Caesarean section |
|
Routine neonatal postextubation chest physiotherapy: A randomized controlled trial |
|
Catherine Bagley |
Recruitment complete
|
|
|
|
APTS - Australian Placental Transfusion Study |
NHMRC571309; ACTRN12610000633088 |
NHMRC Clinical Trials Centre, The University of Sydney, NSW apts@ctc.usyd.edu.au |
Recruitment complete
|
|
|
|
PROVIDE - Impact of Protein IVN on Development: for extremely low birthweight babies, does higher intravenous protein intake in the first 5 days after birth improve neurodevelopmental outcome, growth and body composition through to 2 years of age? |
ACTRN12612001084875 |
Liggins Institute, University of Auckland, Barbara Cormack bcormack@adhb.govt.nz |
Currently recruiting
IMPACT reviewed
|
Protein, intravenous nutrition, neurodevelopment |
Birthweight <1000 g |
View |
MBM - My Baby’s Movements: a stepped wedge cluster randomised controlled trial to raise maternal awareness of fetal movements during pregnancy |
ACTRN12614000291684 |
Mater Research Institute - The University of Queensland u.chandrasiri@mater.uq.edu.au |
Not yet recruiting
IMPACT endorsed
|
Stillbirth prevention. Fetal surveillance. Parental social and emotional wellbeing. |
Pregnant women without any congenital abnormalities |
View |
STRIDER (NZAus)- A randomised placebo-controlled trial of a new therapy (sildenafil) to help growth in severely growth restricted fetuses at very early gestations |
ACTRN12612000584831 |
Department of Obstetrics and Gynaecology, University of Auckland Laura Mackay (Trial Manager) laura.mackay@auckland.ac.nz; Dr Katie Groom (Chief Investigator) k.groom@auckland.ac.nz |
Recruitment complete
IMPACT reviewed
|
Fetal growth. Preeclampsia. Pterterm birth - prevention and treatment |
Women with pregnancies complicated early onset fetal growth restriction. Abdominal circumference ≤3rd centile at 22-28 weeks or EFW <700g at 28-80 weeks |
View |
LIFT - Lactoferrin Infant Feeding Trial to prevent sepsis and death in preterm infants |
ACTRN12611000247976 |
NHMRC Clinical Trial Centre, NSW
lift@ctc.usyd.edu.au |
Currently recruiting
IMPACT reviewed
|
|
|
View |
MAGENTA - Does antenatal magnesium sulphate given to women at risk of preterm birth between 30 and 34 weeks' gestation reduce the risk of death or cerebral palsy in their children? - a randomised controlled trial. |
ACTRN126110000491965 |
University of Adelaide, Clinical Trial Manager Pat Ashwood +61 8 8161 7767
|
Currently recruiting
IMPACT reviewed
|
Neuroprotection, Antenatal magnesium sulphate, Cerebral palsy
|
Women at risk of preterm birth between 30 and 34 weeks’ gestation where birth is planned or definitely expected within 24 hours, have a singleton or twin pregnancy, no contraindications to the use of antenatal magnesium sulphate |
View |
PAEAN - Preventing Adverse Outcomes of Neonatal Hypoxic Ischaemic Encephalopathy with Erythropoietin: a randomised placebo controlled multicentre clinical trial |
ACTRN12614000669695 |
NHMRC Clinical Trials Centre, University of Sydney
paean@ctc.usyd.edu.au
+61 2 9562 5000
|
Currently recruiting
IMPACT reviewed
|
Newborn – developmental |
|
View |
DIAMOND - DIfferent Approaches to MOderate & later preterm Nutrition: Determinants of feed tolerance, body composition and development |
ACTRN12616001199404 |
Liggins Institute, University of Auckland
t.alexander@auckland.ac.nz |
Currently recruiting
IMPACT endorsed
|
Newborn nutrition Newborn body composition Neurodevelopment |
Preterm babies between 32+0 - 35+6 admitted to the neonatal unit requiring IV insertion |
View |
EPPI Trial - Enoxaparin for the Prevention of Preeclampsia and Intrauterine growth restriction ? a pilot randomised placebo-controlled trial |
ACTRN12609000699268 |
Department of Obstetrics and Gynaecology, University of Auckland. Laura Mackay (Trial Manager) laura.mackay@auckland.ac.nz; Dr Katie Groom (Chief Investigator) k.groom@auckland.ac.nz |
Recruitment complete
IMPACT reviewed
|
Fetal growth. Preeclampsia |
Women with previous pregnancy complicated by early onset preeclampsia or fetal growth restriction |
View |
POP-OUT - Persistent Occiput Posterior: OUTcomes following manual rotation |
ACTRN12612001312831 |
Royal Prince Alfred Hospital, NSW hala.phipps@email.cs.nsw.gov.au |
Recruitment complete
IMPACT reviewed
|
Labour and intrapartum care |
|
View |
PROTECT - Can Pentoxifylline improve long-term outcomes in preterm infants with late-onset sepsis or necrotizing enterocolitis? A pragmatic, randomized, controlled trial |
ACTRN12616000405415 |
NHMRC Clinical Trial Centre, NSW
protect@ctc.usyd.edu.au
|
Currently recruiting
IMPACT reviewed
|
Preterm infant sepsis and inflammation, neurodevelopment |
Born at less than 29 weeks gestational age with suspected late-onset sepsis or necrotizing enterocolitis |
View |
CIRCA DIEM |
ACTRN12618000371291p |
Jane Pillow
+61417621960
jane.pillow@uwa.edu.au
The University of Western Australia |
Not yet recruiting
IMPACT endorsed
|
Newborn – developmental
|
Babies born at < 31 weeks and 6 days postmenstrual age. Have initial care at a perinatal centre where routine care does not include individual environmental light/noise cycling. |
View |
The PROTECT Me trial |
RES-17-0000-583A |
Monash Medical Centre Clayton
Dr Kirsten Palmer
kirsten.palmer@monash.edu |
Currently recruiting
IMPACT endorsed
|
Early onset Intrauterine Fetal Growth Restriction |
Women with pregnancies complicated by severe fetal growth restriction between 23+0 and 31+6 weeks gestation |
View |